Across TCGA pan-cancer cohorts, RNU6-849P RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated RNU6-849P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RNU6-849P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-849P expression acts as an unfavorable survival marker.

BLCA and UCEC are the cancer types where RNU6-849P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.163	0.625	.018	45	view →
UCEC	DFS	Tertile	All	0.322	0.649	.004	36	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: RNU6-849P tumor-vs-normal RNA expression · all RNU6-849P data types